These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8679291)

  • 1. Temporal relationship between elongation of the HIV type 1 glycoprotein 120 V2 domain and the conversion toward a syncytium-inducing phenotype.
    Fouchier RA; Broersen SM; Brouwer M; Tersmette M; Van't Wout AB; Groenink M; Schuitemaker H
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1473-8. PubMed ID: 8679291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.
    Cornelissen M; Hogervorst E; Zorgdrager F; Hartman S; Goudsmit J
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1169-75. PubMed ID: 8573372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo sequence changes of HIV-1 envelope V2 and V3 loops.
    Shioda T; Oka S; Nagai Y
    Leukemia; 1997 Apr; 11 Suppl 3():131-3. PubMed ID: 9209320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of phenotype evolution of HIV-1 to envelope V2 configuration.
    Groenink M; Fouchier RA; Broersen S; Baker CH; Koot M; van't Wout AB; Huisman HG; Miedema F; Tersmette M; Schuitemaker H
    Science; 1993 Jun; 260(5113):1513-6. PubMed ID: 8502996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of natural sequence variation in the V2 region of the envelope protein of human immunodeficiency virus type 1 on syncytium induction: a mutational analysis.
    Andeweg AC; Boers PH; Osterhaus AD; Bosch ML
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1901-7. PubMed ID: 7636471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.
    De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J
    AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1503-7. PubMed ID: 8911575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype.
    Bhattacharyya D; Brooks BR; Callahan L
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):83-90. PubMed ID: 8834457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.
    Fouchier RA; Brouwer M; Broersen SM; Schuitemaker H
    J Clin Microbiol; 1995 Apr; 33(4):906-11. PubMed ID: 7790458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype.
    Kuiken CL; de Jong JJ; Baan E; Keulen W; Tersmette M; Goudsmit J
    J Virol; 1992 Jul; 66(7):4622-7. PubMed ID: 1602564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
    Jansson M; Backström E; Scarlatti G; Björndal A; Matsuda S; Rossi P; Albert J; Wigzell H
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1405-14. PubMed ID: 11679153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
    van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
    J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of HIV-1 envelope V2 and V3 sequences of the primary isolates to the viral phenotype.
    Yoshimura K; Matsushita S; Hayashi A; Takatsuki K
    Microbiol Immunol; 1996; 40(4):277-87. PubMed ID: 8709863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1.
    McDonald RA; Chang G; Michael NL
    J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype.
    Innocenti-Francillard P; Brengel K; Guillon C; Mallet F; Morand P; Gruters R; Seigneurin JM
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):683-90. PubMed ID: 8074932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression.
    Shioda T; Oka S; Xin X; Liu H; Harukuni R; Kurotani A; Fukushima M; Hasan MK; Shiino T; Takebe Y; Iwamoto A; Nagai Y
    J Virol; 1997 Jul; 71(7):4871-81. PubMed ID: 9188549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells.
    Holm-Hansen C; Grothues D; Rustad S; Røsok B; Pascu FR; Asjö B
    AIDS Res Hum Retroviruses; 1995 May; 11(5):597-603. PubMed ID: 7576916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.